Internal Medicine, Hematology & Oncology · Fort Smith, AR
NPI
1407877947
Since 2006
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
2
Medicare group memberships
Hospitals
4
Hospital affiliations
7301 Rogers Ave
Fort Smith, AR, 72903
Phone (479) 274-6200
Groups this clinician bills Medicare through
Medicare paid, 2024
$242K
4,530 services
Medicare patients, 2024
777
Average age 74
Drug cost, 2024
$5.7M
2,722 prescriptions
Company payments, 2025
$1,222
From 19 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Daniel W Mackey was code M0010 (enhancing oncology model (eom) monthly enhanced oncology services (meos) payment for eom enhanced services), 1,256 times for 199 patients. In total Daniel W Mackey billed 4,530 services in 25 codes, and Medicare paid $242K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2015-08-31.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|
| M0010 Enhancing oncology model (eom) monthly enhanced oncology services (meos) payment for eom enhanced services | Office | 1,256 | 199 | $72.32 | $91K |
| 36415 Venipuncture Blood Collection | Office | 1,081 | 439 | $8.64 | $9,343 |
| 99214 Office E&M - Established | Office | 1,025 | 451 | $83.83 | $86K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 573 | 317 | $11.78 | $6,753 |
| 99213 Office E&M - Established | Office | 201 | 180 | $41.08 | $8,258 |
| 99215 Office E&M - Established | Office | 167 | 111 | $121.90 | $20K |
| 99204 Office E&M - New | Office | 124 | 124 | $109.50 | $14K |
| 99231 Hospital E&M - Subsequent | Facility | 34 | 24 | $34.69 | $1,180 |
| 38222 Other Organ Systems | Office | 16 | 14 | $114.61 | $1,834 |
| 99232 Hospital E&M - Subsequent | Facility | 13 | 11 | $57.11 | $742 |
By year: 2022 $140K for 2,650 services; 2023 $175K for 3,271 services; 2024 $242K for 4,530 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 1,081 | 439 | $8.64 | $9,343 |
Medicare prescription drug claims, 2024
In 2024, the drug Daniel W Mackey prescribed most often to Medicare patients was Hydrocodone-Acetaminophen (Hydrocodone/Acetaminophen), with 237 prescriptions and refills. In total Daniel W Mackey wrote 2,722 Medicare prescriptions that cost $5.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 237 | 237 | 65 | $4,990 |
| Anastrozole Generic | 193 | 365 | 48 | $2,592 |
| Ondansetron Hcl Generic | 131 | 134 | 73 | $1,022 |
| Duloxetine Hcl Generic | 103 | 130 | 30 | $1,351 |
| Promethazine Hcl Generic | 93 | 93 | 54 | $537 |
| Letrozole Generic | 91 | 204 | 25 | $1,520 |
| Levothyroxine Sodium Generic | 86 | 124 | 23 | $306 |
| Eliquis Apixaban | 83 | 87 | 18 | $46K |
| Prednisone Generic | 65 | 68 | 33 | $227 |
| Potassium Chloride Generic | 65 | 72 | 22 | $931 |
| Lidocaine-Prilocaine Lidocaine/Prilocaine | 62 | 62 | 49 | $766 |
| Acyclovir Generic | 57 | 75 | 12 | $990 |
| Morphine Sulfate Er Morphine Sulfate | 52 | 52 | Under 11 | $1,557 |
| Lorazepam Generic | 48 | 50 | 25 | $184 |
| Gabapentin Generic | 45 | 63 | Under 11 | $874 |
Brand drugs: 554 claims; generic drugs: 2,168 claims; opioid claims: 392.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Daniel W Mackey $1,222 ($1,222 in general payments such as food, travel and fees) from 19 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $268.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 12 | $268 |
| Abbvie Inc. ABBV | 13 | $204 |
| Daiichi Sankyo Inc. 4568.T | 7 | $169 |
| GlaxoSmithKline, LLC. GSK | 7 | $109 |
| Tempus AI, Inc TEM | 2 | $107 |
| Merck Sharp & Dohme LLC MRK | 4 | $63.83 |
| Pfizer Inc. PFE | 3 | $57.06 |
| Karyopharm Therapeutics Inc. KPTI | 2 | $32.76 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 1 | $30.73 |
| Sumitomo Pharma America, Inc. 4506.T | 1 | $29.38 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.